Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG)
Modern Rheumatology · 2024
DOI: 10.1093/mr/roae040 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Mochihito Suzuki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Aichi, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Disability Evaluation, Severity of Illness Index, Activities of Daily Living. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objectives
The present study aimed to examine discrepancies between assessments based on Routine Assessment of Patient Index Data 3 (RAPID3) and Simple Disease Activity Index (SDAI) in rheumatoid arthritis (RA) patients with controlled disease activity.
Methods
Data from 464 RA patients in SDAI remission or low disease activity (REM/LDA) were analysed. Patient-reported outcome (PRO) measures, including Health Assessment Questionnaire Disability Index (HAQ-DI), 25-question Geriatric Locomotive Function Scale (GLFS-25), and Kihon checklist (KCL), were assessed. Logistic regression models were used to identify factors associated with RAPID3 moderate or high disease activity (MDA/HDA). Cutoff values of RAPID3 MDA/HDA for each PRO evaluation item were determined using receiver operating characteristic curve analysis.
Results
Among RA patients in SDAI REM/LDA, 84.9% were in RAPID3 REM/LDA. Multivariable analysis revealed that HAQ-DI, GLFS-25, and KCL were independently associated with RAPID3 MDA/HDA. Subdomain analysis of KCL revealed that activities of daily living, physical function, cognitive function, and depressive mood were significantly associated with RAPID3 MDA/HDA. Cutoff values for HAQ-DI and KCL were 0.38 and 8, respectively.
Conclusions
In RA patients with controlled disease activity, discrepancies between RAPID3 and SDAI assessments were observed, with factors such as HAQ-DI, GLFS-25, and KCL being independently associated with RAPID3 MDA/HDA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Aichi, Japan.
- Department of Orthopedic Surgery, Japan Community Health care Organization Kani Tono Hospital, Gifu, Japan.
- Department of Orthopedic Surgery, Yokkaichi Municipal Hospital, Mie, Japan.
- Department of Orthopedic Surgery, Aichi Medical University, Aichi, Japan.
- Department of Orthopedic Surgery, Japanese Red Cross Nagoya Daiichi Hospital, Aichi, Japan.
ORCID-Profile: Mochihito Suzuki, Shuji Asai, Kenya Terabe, Shiro Imagama
Zitieren
APA
Suzuki, M., Asai, S., Ohashi, Y., Sobue, Y., Ishikawa, H., Takahashi, N., Terabe, K., Sato, R., Kosugiyama, H., Hasegawa, J., Ohno, Y., Sugiura, T., & Imagama, S. (2024). Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG). Modern Rheumatology. https://doi.org/10.1093/mr/roae040
Vancouver
Suzuki M, Asai S, Ohashi Y, Sobue Y, Ishikawa H, Takahashi N, et al. Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG). Modern Rheumatology. 2024. doi:10.1093/mr/roae040
BibTeX
@article{Suzuki2024,
author = {Suzuki, Mochihito and Asai, Shuji and Ohashi, Yoshifumi and Sobue, Yasumori and Ishikawa, Hisato and Takahashi, Nobunori and Terabe, Kenya and Sato, Ryo and Kosugiyama, Hironobu and Hasegawa, Junya and Ohno, Yusuke and Sugiura, Takaya and Imagama, Shiro},
title = {Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG)},
journal = {Modern Rheumatology},
year = {2024},
doi = {10.1093/mr/roae040}
}
EUVIMED